Loading…
Zydus Lifesciences (ZYDUSLIFE)₹1,216+1.37%Pharmaceuticals
Zydus Lifesciences is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 27.0 against a peer median of 41.2, and ROCE of 21.1% against a peer median of 15.0%, and latest-quarter sales growth of 21.8% against a peer median of 17.4%. By market cap it is #3 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | 1,81,640 | 79.0 | 15.0 | 27.5 | 0.77 | 0.8 | 14,003 | 2,147 | 50.8 | −9.6 | vs ZYDUSLIFE |
| Laurus Labs | 1,32,516 | 98.6 | 18.0 | 18.3 | 0.48 | 0.1 | 6,795 | 890 | 33.3 | 124.7 | vs ZYDUSLIFE |
| Zydus Lifesciences | 1,21,347 | 27.0 | 21.1 | 21.2 | 0.46 | 0.1 | 27,233 | 5,129 | 21.8 | −35.0 | — |
| Dr. Reddy's Laboratories | 1,15,648 | 41.2 | 13.0 | 11.2 | 0.19 | 0.6 | 33,781 | 4,160 | −1.4 | −31.7 | vs ZYDUSLIFE |
| Cipla | 1,13,427 | 39.2 | 15.0 | 11.7 | 0.02 | 0.9 | 28,258 | 3,871 | −2.5 | −37.1 | vs ZYDUSLIFE |
| Mankind Pharma | 1,10,201 | 49.0 | 14.0 | 13.1 | 0.31 | 0.0 | 14,271 | 1,942 | 17.4 | 37.7 | vs ZYDUSLIFE |
| Aurobindo Pharma | 1,07,793 | 29.0 | 13.0 | 10.2 | 0.21 | 0.0 | 33,715 | 3,490 | 16.4 | 25.2 | vs ZYDUSLIFE |
| Lupin | 92,543 | 16.7 | 29.9 | 28.7 | 0.29 | 0.9 | 28,016 | 5,347 | 32.1 | 16.2 | vs ZYDUSLIFE |
| Glenmark Pharmaceuticals | 75,325 | 42.0 | 40.1 | 30.5 | 0.06 | 0.1 | 16,989 | 1,362 | 23.2 | 927.6 | vs ZYDUSLIFE |
| Alkem Laboratories | 64,547 | 29.9 | 21.0 | 18.8 | 0.15 | 1.0 | 14,712 | 2,360 | 11.0 | −22.0 | vs ZYDUSLIFE |
| Biocon | 60,066 | 108.4 | 4.0 | 1.4 | 0.45 | 0.1 | 16,993 | 369 | 10.0 | 54.0 | vs ZYDUSLIFE |
| Peer median | 1,10,201 | 41.2 | 15.0 | 18.3 | 0.29 | 0.1 | 16,993 | 2,360 | 17.4 | 16.2 |
Listed companies closest to Zydus Lifesciences in Pharmaceuticals include Torrent Pharmaceuticals, Laurus Labs, Dr. Reddy's Laboratories, Cipla, Mankind Pharma, Aurobindo Pharma, Lupin, Glenmark Pharmaceuticals.
Torrent Pharmaceuticals, with a market cap of ₹1.82 L Cr.
Zydus Lifesciences trades at a P/E of 27.0; the median of its peer set is 41.2. A P/E above or below the median is a description, not a judgement on value.
Zydus Lifesciences' return on capital employed is 21.1%, above the peer median of 15.0%.